YU227290A - Farmaceutski preparati - Google Patents

Farmaceutski preparati

Info

Publication number
YU227290A
YU227290A YU227290A YU227290A YU227290A YU 227290 A YU227290 A YU 227290A YU 227290 A YU227290 A YU 227290A YU 227290 A YU227290 A YU 227290A YU 227290 A YU227290 A YU 227290A
Authority
YU
Yugoslavia
Prior art keywords
weight
denotes
pharmaceutical preparations
polyloxyethylene
pyrid
Prior art date
Application number
YU227290A
Other languages
English (en)
Inventor
W. Fries
Original Assignee
Heinrich Mack Nachf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heinrich Mack Nachf. filed Critical Heinrich Mack Nachf.
Publication of YU227290A publication Critical patent/YU227290A/sh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Abstract

FARMACEUTSKI PREPARATI, ovaj pronalazak se odnosi na farmaceutski preparat za parenteralno davanje leka koji se sastoji od rastvaračkog sistema koji se sastoji od 0-65 mas.% - tetrahidrofurfuril- - hidroksi-polioksietilena; 10-100 mas.% polietilen glikola sa srednjom molekulskom msom od 200 do 600 i 0-35 mas.% vode; pri čemu komponente izuzev vode dostižu vrednost od najmanje 65 mas.% a jedna ili više terapeutski aktivnih komponenata ima formulu: gde je R1 fenil radikal po želji supstituisan sa 1 do 3 supstituenata nezavisno izabranih iz grupe koja se sastoji od F, C1, Br, I, CF3, C1 do C4 alkil, i C1-C4 alkoksi, ili 5-hloro-pirid-2-il; X predstavlja OH, F, C1 ili Br; R2 je H, CH3 ili F; R3 je H ili F.
YU227290A 1989-11-29 1990-11-28 Farmaceutski preparati YU227290A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939492A DE3939492A1 (de) 1989-11-29 1989-11-29 Pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
YU227290A true YU227290A (sh) 1993-10-20

Family

ID=6394433

Family Applications (1)

Application Number Title Priority Date Filing Date
YU227290A YU227290A (sh) 1989-11-29 1990-11-28 Farmaceutski preparati

Country Status (29)

Country Link
US (1) US5118698A (sh)
EP (1) EP0430149B1 (sh)
JP (1) JPH0660097B2 (sh)
KR (1) KR940000066B1 (sh)
CN (1) CN1035357C (sh)
AT (1) ATE102051T1 (sh)
AU (1) AU626480B2 (sh)
BR (1) BR9006025A (sh)
CA (1) CA2030911C (sh)
CY (1) CY1970A (sh)
CZ (1) CZ282898B6 (sh)
DE (2) DE3939492A1 (sh)
DK (1) DK0430149T3 (sh)
EG (1) EG19557A (sh)
ES (1) ES2062271T3 (sh)
FI (1) FI103713B (sh)
HK (1) HK216896A (sh)
HU (1) HU220867B1 (sh)
IE (1) IE64672B1 (sh)
IL (1) IL96450A (sh)
MX (1) MX23518A (sh)
MY (1) MY104540A (sh)
NO (1) NO180475C (sh)
NZ (1) NZ236255A (sh)
PT (1) PT96003B (sh)
RU (1) RU2038080C1 (sh)
SK (1) SK280599B6 (sh)
YU (1) YU227290A (sh)
ZA (1) ZA909549B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
AU7880991A (en) * 1990-05-10 1991-11-27 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
JP3485540B2 (ja) * 2000-12-28 2004-01-13 新日本製鐵株式会社 低騒音トランス
ES2331058T3 (es) * 2001-02-28 2009-12-21 Intervet International Bv Emulsiones de agua en aceite inyectables.
AU2003210517A1 (en) 2002-02-04 2003-09-02 Elan Pharma International, Ltd. Drug nanoparticles with lysozyme surface stabiliser
EP1551457A1 (en) * 2002-07-16 2005-07-13 Elan Pharma International Limited Liquid dosage compositions of stable nanoparticulate active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GR79307B (sh) * 1982-06-09 1984-10-22 Pfizer
AU4882685A (en) * 1984-10-19 1986-04-24 Schering Corporation 1,3-bis(1h-1,2,4-triazol-1-yl)-2-fluoro-2-(2,4- difluorophenyl) propane

Also Published As

Publication number Publication date
CA2030911A1 (en) 1991-05-30
SK595390A3 (en) 2000-04-10
FI905814A0 (fi) 1990-11-26
DE69007029D1 (de) 1994-04-07
FI103713B1 (fi) 1999-08-31
DE69007029T2 (de) 1994-06-09
PT96003A (pt) 1991-09-13
DK0430149T3 (da) 1994-03-28
NO180475B (no) 1997-01-20
CN1052046A (zh) 1991-06-12
EP0430149A2 (en) 1991-06-05
BR9006025A (pt) 1991-09-24
CY1970A (en) 1997-09-05
NZ236255A (en) 1992-02-25
IE904282A1 (en) 1991-06-05
NO905106L (no) 1991-05-30
DE3939492A1 (de) 1991-06-06
ZA909549B (en) 1992-06-24
IL96450A (en) 1994-10-21
US5118698A (en) 1992-06-02
HUT57039A (en) 1991-11-28
SK280599B6 (sk) 2000-04-10
ATE102051T1 (de) 1994-03-15
IE64672B1 (en) 1995-08-23
JPH0660097B2 (ja) 1994-08-10
CN1035357C (zh) 1997-07-09
HU220867B1 (en) 2002-06-29
RU2038080C1 (ru) 1995-06-27
FI905814A (fi) 1991-05-30
EG19557A (en) 1997-08-31
ES2062271T3 (es) 1994-12-16
NO180475C (no) 1997-04-30
NO905106D0 (no) 1990-11-26
JPH03176421A (ja) 1991-07-31
CZ282898B6 (cs) 1997-11-12
EP0430149A3 (en) 1991-09-25
KR940000066B1 (ko) 1994-01-05
EP0430149B1 (en) 1994-03-02
HK216896A (en) 1996-12-27
AU6706590A (en) 1991-08-08
FI103713B (fi) 1999-08-31
MX23518A (es) 1993-04-01
KR910009286A (ko) 1991-06-28
CZ595390A3 (en) 1997-06-11
AU626480B2 (en) 1992-07-30
MY104540A (en) 1994-04-30
PT96003B (pt) 1998-01-30
CA2030911C (en) 1995-02-07

Similar Documents

Publication Publication Date Title
ATE68180T1 (de) Morpholinoethylester von mycophenolsaeure und ihre derivate, ihre herstellung und verwendung in pharmazeutische zusammensetzungen.
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69011569T2 (de) Verbindungen der 1-Azabicyclo(3.2.0)hept-2-en-2-carbonsäure.
NO155884C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
DE68917357D1 (de) Derivate der Coffeinsäure und pharmazeutische Zusammensetzungen, die sie enthalten.
SE7906472L (sv) Nya 3-(aminoetyl)-fenol-derivat och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
FR2669927B1 (fr) Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
YU227290A (sh) Farmaceutski preparati
FI104071B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 2,5-dihydro-2,5-diokso-1H-bents£b|atsepiinijohdannaisten valmistamiseksi
DK451389A (da) 2-substituerede 4,5-diaryl-thioimidazoler samt farmaceutisk praeparat indeholdende saadanne forbindelser
MX9206930A (es) Nuevos compuestos
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
ATE34739T1 (de) Neue 2-pyridin-thiol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
FR2682952B1 (fr) Nouveaux n-(mercaptoacyl) amino-acides, leur preparation et les compositions pharmaceutiques qui les contiennent.
SE8000699L (sv) Nya kinazolinderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem
SE8100122L (sv) Nya 2-aminometyl-6-halo-fenoler, framstellning derav och farmaceutiska kompositioner innehallande dessa
KR890013001A (ko) 자극성 아미노산 수용체 길항제인 테트라졸 유도체